Scrip has fully bottomed out, resting on 200 Week MA.
It is also in a declining triangle, with a firm flat support between 148 ~ 163.
It needs a breakout, although pricewise it has reared its head up at Rs 170 now.
Catch in an infant stage is what it is presently appearing and once pharma industry develops fancy - which it should now soon anytime - with stabilisation of Trump's policies, it will race ahead dramatically.
All fundamental parameters are encouraging. Rs . 220 would be the first strong resistance and thereafter I daresay, Rs 445 may not be far away - say in a year's time frame !!!
Just Buy and hold with a stoploss of Rs 148.